Basilea Pharmaceutica AG (OTCMKTS:BPMUF) Short Interest Update

Basilea Pharmaceutica AG (OTCMKTS:BPMUF) saw a significant increase in short interest in the month of June. As of June 15th, there was short interest totalling 89,800 shares, an increase of 19.9% from the May 31st total of 74,900 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ? days.

Basilea Pharmaceutica Price Performance

Shares of OTCMKTS BPMUF opened at $48.15 on Monday. The business’s 50 day moving average is $46.60 and its two-hundred day moving average is $42.83. Basilea Pharmaceutica has a 52-week low of $38.60 and a 52-week high of $48.15.

About Basilea Pharmaceutica

Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.